Chemical Name: 5-(3-Methylphenoxy)-2(1H)-pyrimidinone
Biological ActivitySelective allosteric activator of Lyn kinase (EC50 = 63 nM); displays no significant activity against a range of 47 other kinases, including other Src family kinases such as Fyn, Lck and Src kinase. Reduces blood glucose levels without affecting in vivo insulin secretion. Orally bioavailable.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivo.
Saporito et al.
The Lyn kinase activator MLR-1023 is a novel Ins receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes.
Ochman et al.
Citation for MLR 1023
The citations listed below are publications that use Tocris products. Selected citations for MLR 1023 include:
1 Citation: Showing 1 - 1
Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy.
Authors: Iida Et al.
Nat Commun 2019;10:4262
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for MLR 1023
There are currently no reviews for this product. Be the first to review MLR 1023 and earn rewards!
Have you used MLR 1023?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image